Sirolimus for kaposiform hemangioendothelioma: Potential mechanisms of action and resistance. Qiu T, Xiang S, Zhou J, Yang M, et al. Int J Cancer 2024 Oct 6. doi: 10.1002/ijc.35207.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qiu T, Xiang S, Zhou J, Yang M, et al. Sirolimus for kaposiform hemangioendothelioma: Potential mechanisms of action and resistance. Int J Cancer 2024 Oct 6. doi: 10.1002/ijc.35207.
PMID: 39369447